These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2738906)

  • 1. Lethal osteogenesis imperfecta.
    Knisely AS; Abuelo D; Byers PH
    J Med Genet; 1989 Jun; 26(6):410-1. PubMed ID: 2738906
    [No Abstract]   [Full Text] [Related]  

  • 2. Lethal osteogenesis imperfecta associated with 46,XY,inv(7)(p13q22) karyotype.
    Knisely AS; Richardson A; Abuelo D; Casey S; Singer DB
    J Med Genet; 1988 May; 25(5):352-5. PubMed ID: 3385745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.
    Cohn DH; Byers PH; Steinmann B; Gelinas RE
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6045-7. PubMed ID: 3016737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.
    Constantinou CD; Nielsen KB; Prockop DJ
    J Clin Invest; 1989 Feb; 83(2):574-84. PubMed ID: 2913053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cysteine substitutions in procollagen I: a glycine replacement near the N-terminus of alpha 1(I) chain causes lethal osteogenesis imperfecta and a glycine replacement in the alpha 2(I) chain markedly destabilizes the triple helix.
    Fertala A; Westerhausen A; Morris G; Rooney JE; Prockop DJ
    Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):195-9. PubMed ID: 8424758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenesis imperfecta: translation of mutation to phenotype.
    Byers PH; Wallis GA; Willing MC
    J Med Genet; 1991 Jul; 28(7):433-42. PubMed ID: 1895312
    [No Abstract]   [Full Text] [Related]  

  • 7. A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseases.
    Pace JM; Chitayat D; Atkinson M; Wilcox WR; Schwarze U; Byers PH
    J Med Genet; 2002 Jan; 39(1):23-9. PubMed ID: 11826020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.
    Pihlajaniemi T; McKeon J; Gay S; Gay R; de Wet WJ; Myers JC; Prockop DJ
    Biochem J; 1989 Jan; 257(2):439-45. PubMed ID: 2649075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal osteogenesis imperfecta and a gene deletion.
    Sykes B; Ogilvie D
    Br Med J (Clin Res Ed); 1984 May; 288(6427):1380-1. PubMed ID: 6424862
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduced secretion of structurally abnormal type I procollagen in a form of osteogenesis imperfecta.
    Barsh GS; Byers PH
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5142-6. PubMed ID: 6946461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in type I procollagen genes that cause osteogenesis imperfecta.
    Prockop DJ; Baldwin CT; Constantinou CD
    Adv Hum Genet; 1990; 19():105-32. PubMed ID: 2193488
    [No Abstract]   [Full Text] [Related]  

  • 12. The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix.
    Cole WG; Chow CW; Bateman JF; Sillence DO
    J Med Genet; 1996 Nov; 33(11):965-7. PubMed ID: 8950680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinatal lethal osteogenesis imperfecta.
    Cole WG; Dalgleish R
    J Med Genet; 1995 Apr; 32(4):284-9. PubMed ID: 7643358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene.
    Stacey A; Bateman J; Choi T; Mascara T; Cole W; Jaenisch R
    Nature; 1988 Mar; 332(6160):131-6. PubMed ID: 2450280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in osteogenesis imperfecta leading to the synthesis of abnormal type I procollagens.
    Prockop DJ; Chu ML; de Wet W; Myers JC; Pihlajaniemi T; Ramirez F; Sippola M
    Ann N Y Acad Sci; 1985; 460():289-97. PubMed ID: 3868953
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct sequencing of PCR products derived from cDNAs for the pro alpha 1 and pro alpha 2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta.
    Zhuang J; Tromp G; Kuivaniemi H; Castells S; Bugge M; Prockop DJ
    Hum Mutat; 1996; 7(2):89-99. PubMed ID: 8829649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
    Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lethal osteogenesis imperfecta. Definition and heterogeneity].
    Maroteaux P; Cohen-Solal L
    Ann Genet; 1984; 27(1):11-5. PubMed ID: 6609668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen.
    Cole WG; Chow CW; Rogers JG; Bateman JF
    J Med Genet; 1990 Apr; 27(4):228-35. PubMed ID: 2325102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations linked to the pro alpha 2(I) collagen gene are responsible for several cases of osteogenesis imperfecta type I.
    Wallis G; Beighton P; Boyd C; Mathew CG
    J Med Genet; 1986 Oct; 23(5):411-6. PubMed ID: 3023615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.